期刊
STEM CELLS AND DEVELOPMENT
卷 15, 期 3, 页码 381-389出版社
MARY ANN LIEBERT INC
DOI: 10.1089/scd.2006.15.381
关键词
-
资金
- NATIONAL INSTITUTE ON AGING [R01AG023472] Funding Source: NIH RePORTER
- NIA NIH HHS [R01AG 23472] Funding Source: Medline
Although amyloid beta(A beta) deposition has been a hallmark of Alzheimer's disease (AD), the absence of a phenotype in the beta amyloid precursor protein (APP) knockout mouse, tends to detract our attention away from the physiological functions of APP. Although much attention has been focused on the neurotoxicity of A beta, many studies suggest the involvement of APP in neuroplasticity. We found that secreted amyloid precursor protein ( sAPP) increased the differentiation of human neural stem cells (hNSCs) in vitro, while an antibody-recognizing APP dose-dependently inhibited these activities. With a high dose of sAPP treatment or wild-type APP gene transfection, hNSCs were differentiated into astrocytes rather than neurons. In vivo, hNSCs transplanted into APP-transgenic mouse brain exhibited glial differentiation rather than neural differentiation. Our results suggest that APP regulates neural stem cell biology in the adult brain, and that altered APP metabolism in Down syndrome or AD may have implications for the pathophysiology of these diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据